Portal de Periódicos da CAPES

Comment on: ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al

2020; BMJ; Volume: 82; Issue: 3 Linguagem: Inglês

10.1136/annrheumdis-2020-218497

1468-2060

Samet Karahan, Ali Çetinkaya, Kaniye Aydın, Hatice Aslan Sırakaya,

Long-Term Effects of COVID-19

We read with great interest the article by Gianfrancesco et al concerning characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. In this study, the authors mentioned that glucocorticoid exposure of ≥10 mg/day is associated with higher odds of hospitalisation and antitumour necrosis factor with decreased odds of hospitalisation in patients with rheumatic disease.1 We also aimed to present a case of microscopic polyanitis (MPA) with a diagnostic challenge with COVID-19 pneumonia. A previously healthy man in his 70s, who had complaints of malaise, fever, cough, tachypnea, dyspnoea was admitted to the emergency. Chest CT (CCT) scan revealed peripheral focal ground-glass opacities (GGOs) and infiltrations in the lower and upper lobes on the right and the left middle zones (figure 1). The patient was admitted to the intensive care unit with a prediagnosis of COVID-19 pneumonia and was intubated due to severe acute respiratory failure. Two nasopharyngeal swabs had …